C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home Markets Loading…
CLEU Equity

CLEU

OTCMKTS · CLEU

$0.10
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 3/5
36/100 composite
Fundamentals27
Regulatory50
Market40
Editorial30
Composite · trailing 12 months

Clearleaf US (CLEU) has been given a Neutral rating within the respected band according to the latest evaluation. This reflects a composite score of 36.5 with moderate conviction of 3/5. Among the four pillars—fundamentals, regulatory, market, and editorial—the regulatory environment emerged as the prime contributor with a score of 50.0, signifying relative stability within its LATAM jurisdiction. Conversely, the fundamentals pillar lags with a score of 27.0, illustrating a need for improvement in financial metrics.

From available data, CLEU's fundamentals appear particularly strained. The company is experiencing a significant year-over-year revenue decline. However, the gross margin remains robust, allowing room for potential financial re-engineering. Concerns persist with regard to profitability, as indicated by a negative operating margin and sizeable negative EBITDA, alongside a cash burn ratio that suggests limited runway before additional capital may be required. These dynamics contribute to a broader stretched financial condition. Regulatory scores benefit from CLEU’s unblemished enforcement record and satisfactory jurisdictional posture, despite ongoing issues with filing cadence contributing to lower regulatory cadence subscores.

Looking forward, the most critical aspect to monitor involves the regulatory pillar, given its dominant influence on the overall rating. A strengthening regulatory posture in LATAM may provide a framework for operational stability and growth prospects. Enhanced adherence to regulatory filings and improvements in the jurisdiction's posture could further reinforce CLEU's positioning. With the regulatory environment continuing to drive the composite score, stakeholders should prioritize observing any changes or developments in LATAM regulatory policy closely.

Scored: 2026-08-25Valid through: 2026-10-09Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
IR & AgencyInvestor relations
Corporate DetailsCompany profile
CEO
Lawrence Pratt
CFO
Alejandro Martínez Soto
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$3.5M
Enterprise value
$-81.6M
Price to book
0.00
Price to sales
1.44
EV / EBITDA
10.75
Revenue (TTM)
$2.4M
Gross profit (TTM)
$1.5M
EBITDA
$-5.0M
Operating margin
-520.8%
Profit margin
0.0%
Rev growth YoY
-34.8%
Return on equity
-10.5%
Return on assets
-3.3%
EPS (TTM)
$-4079.38
Shares outstanding
3.4M
Insider ownership
1.5%
Institutional ownership
1.4%
Beta
1.84
Full-time employees
63
GICS sector
Consumer Defensive
GICS industry
Education & Training Services
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for CLEU (CLEU)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for CLEU (CLEU), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for CLEU are maintained by Cannabis Investor News and refreshed throughout the trading day.